2024 European Virtual Ward and Remote Patient Monitoring (RPM) Market Overview and Industry Outlook

Geneva, Switzerland – September 9, 2024

Doccla, a London-based provider of virtual ward and remote patient monitoring services, has raised £35 million in a Series B funding round to expand its operations across Europe. The funding round was led by Lakestar, with additional investment from Elaia, General Catalyst, Bertelsmann Investments, and Speedinvest. Oliver Heimes, a partner at Lakestar, will join Doccla's board.

This fresh investment will support Doccla's efforts to consolidate its presence in the UK and Ireland and further expand into key European markets, particularly France and the DACH region. Doccla, which already monitors patients in over 10 European countries and works with NHS Trusts across more than half of the NHS regions, recently partnered with Ireland’s Health Service Executive (HSE).

Doccla's platform, which provides 24/7 remote monitoring across 40 care pathways, allows healthcare providers to track patient data in real-time, preemptively address health concerns, and reduce emergency hospital admissions. The company's services, regulated by the Care Quality Commission in England, have been pivotal in managing patient care outside traditional hospital settings.

Martin Ratz, Doccla's founder, emphasized that the company’s virtual wards enable early discharge and help prevent hospital admissions for chronic care patients, allowing recovery at home and easing the burden on healthcare providers. Ratz highlighted the company's significant contributions to the NHS and its plans to scale operations and invest in the Life Sciences sector.

Oliver Heimes from Lakestar noted Doccla's rapid rise to becoming a market leader in the UK and expressed confidence in its ability to expand successfully into new markets and diversify its service offerings.

Founded after Martin Ratz experienced a heart attack, Doccla aims to fill the care gap for patients post-hospital discharge, leveraging health technology to enhance patient care at home.

 

窗体顶端

窗体底端

Policy Analysis

Regulatory Frameworks and Policies

European healthcare systems are generally regulated at the national level, but there are overarching EU-wide regulations that impact the virtual ward and RPM industry:

Data Protection and Privacy: The General Data Protection Regulation (GDPR) is a cornerstone of data privacy in Europe. Virtual ward and RPM services rely heavily on real-time data collection and analysis, which necessitates stringent compliance with GDPR to protect patient data. Companies must ensure that data processing is transparent, secure, and that patients provide informed consent for the use of their health data.

Medical Device Regulation (MDR): As virtual ward and RPM technologies often involve medical devices, compliance with the MDR, which came into effect in May 2021, is crucial. This regulation ensures that devices are safe and perform as intended, requiring rigorous testing, certification, and post-market surveillance.

Telemedicine Guidelines: The European Union supports the use of telemedicine through various initiatives, such as the EU4Health program. National healthcare systems within Europe are encouraged to integrate telemedicine into routine healthcare services. Policies vary across countries, with some, like the UK and Germany, having well-defined frameworks supporting telemedicine reimbursement and adoption.

Interoperability Standards: For RPM to be effective, different systems and devices must communicate seamlessly. The EU promotes the adoption of interoperability standards, such as those set by the European Interoperability Framework (EIF), to ensure that data can be easily shared across different platforms and healthcare providers.

Market Drivers

Aging Population: Europe has a rapidly aging population, which increases the demand for healthcare services. Virtual wards and RPM offer a scalable solution to manage chronic diseases and post-hospital care for elderly patients, allowing them to receive care in the comfort of their homes.

Healthcare Cost Containment: Virtual ward and RPM services help reduce healthcare costs by minimizing unnecessary hospital admissions and enabling early intervention. This cost-effectiveness is a significant driver for adoption by national healthcare systems seeking to optimize limited resources.

Technological Advancements: The rise of IoT devices, AI-driven analytics, and telehealth platforms has made remote monitoring more effective and user-friendly. Continuous innovation in these areas is driving the growth of the virtual ward industry.

COVID-19 Pandemic Impact: The pandemic accelerated the adoption of virtual care solutions to limit patient exposure and manage healthcare resources efficiently. This shift has created a lasting impact, making remote monitoring an integral part of healthcare delivery in Europe.

Challenges and Barriers

Regulatory Complexity: Navigating the different regulations across European countries can be complex for companies operating in multiple markets. Harmonizing regulations and ensuring compliance with local laws is a significant challenge.

Data Security Concerns: High-profile data breaches in healthcare have raised concerns about the security of patient data in virtual ward and RPM systems. Ensuring robust cybersecurity measures is essential to maintain trust among patients and healthcare providers.

Reimbursement Models: Varying reimbursement models across countries pose a challenge. While some countries like Germany have established reimbursement frameworks for telehealth services, others are still developing policies, leading to inconsistent adoption rates.

Healthcare Professional Adoption: There may be resistance from healthcare professionals who are accustomed to traditional care models. Training and awareness programs are needed to encourage the adoption of virtual care solutions.

5. Opportunities for Growth

Expansion into New Markets: Companies like Doccla are looking to expand into the DACH region (Germany, Austria, Switzerland) and France, where there is growing interest in digital health solutions. Tailoring services to meet local regulatory and cultural needs will be critical for success.

Partnerships with Healthcare Systems: Collaborations with national healthcare providers, such as Doccla’s partnerships with NHS Trusts in the UK and HSE in Ireland, can enhance service reach and credibility.

Integration with Life Sciences: Expanding virtual ward and RPM services into the Life Sciences sector, including clinical trials and real-world evidence collection, offers new growth avenues. This integration can support pharmaceutical companies in monitoring patient outcomes and enhancing drug safety profiles.

 

Market Overview

Current Market Size and Growth

Growth Rate: QY Research reports project the virtual ward market in Europe to grow at a compound annual growth rate (CAGR) of approximately 11.2% from 2024 to 2030. This growth is fueled by the increasing adoption of healthcare digitalization, government initiatives promoting telehealth, and rising investments from both public and private sectors. The global market size is expected to expand from 765.3 million USD in 2024 to 1446.9 million USD by 2030, reflecting the ongoing transformation of healthcare systems.

Key Market Drivers

Aging Population: Europe has one of the oldest populations globally, leading to a higher prevalence of chronic conditions such as diabetes, cardiovascular diseases, and respiratory disorders. Virtual wards and RPM provide a scalable solution to monitor and manage these conditions, reducing hospital admissions and enabling patients to receive care at home.

Technological Advancements: Innovations in IoT, AI, wearable devices, and telecommunication have made RPM more effective and accessible. These technologies allow continuous monitoring of patients, real-time data analysis, and early detection of health deterioration, which can lead to timely interventions.

Post-COVID-19 Adoption: The pandemic accelerated the adoption of telehealth and RPM as healthcare systems sought to minimize patient exposure to the virus and manage healthcare resources effectively. This shift towards virtual care models has continued post-pandemic, with healthcare providers and patients increasingly comfortable with remote care.

Cost Efficiency: Virtual wards and RPM systems can significantly reduce healthcare costs by minimizing hospital admissions, reducing the length of hospital stays, and lowering the frequency of emergency room visits. This cost-effectiveness makes RPM an attractive option for healthcare providers and insurance companies.

Government Initiatives: Several European governments have introduced policies and funding to support the adoption of digital health solutions. Programs like the EU4Health initiative and national telehealth strategies in countries like the UK, Germany, and France promote the integration of virtual care into healthcare systems.

Key Players in the Market

Doccla: A leading provider in the UK and Ireland, Doccla offers virtual ward services and remote monitoring solutions, working closely with NHS Trusts and expanding across Europe. The recent £35 million funding round will help Doccla increase its footprint in the DACH region and France.

Tunstall Healthcare: Known for its telehealth solutions, Tunstall Healthcare provides RPM services across Europe, focusing on elderly care and chronic disease management.

Philips Healthcare: A major player in the healthcare technology space, Philips offers comprehensive RPM platforms that integrate wearable devices, data analytics, and telehealth services.

GE Healthcare: GE’s RPM solutions include wearable devices and patient monitoring systems that cater to hospitals and home care settings.

Medtronic: A global leader in medical technology, Medtronic provides RPM services that focus on chronic disease management and post-surgical care.

Challenges and Barriers

Regulatory Hurdles: The regulatory landscape in Europe is complex, with different countries having varying standards and requirements for telehealth and RPM solutions. Compliance with the EU’s GDPR and Medical Device Regulation (MDR) adds additional layers of complexity for companies operating across multiple markets.

Data Privacy and Security: Ensuring the security of patient data is a critical concern. High-profile data breaches in healthcare have increased scrutiny, and companies must invest in robust cybersecurity measures to protect sensitive information.

Reimbursement Models: The lack of uniform reimbursement policies for telehealth and RPM services across European countries poses a barrier to widespread adoption. While some countries, like Germany, have established reimbursement frameworks, others are still developing policies.

Integration with Existing Healthcare Systems: Seamlessly integrating virtual ward and RPM solutions with existing healthcare infrastructure and electronic health records (EHRs) can be challenging. Interoperability standards are crucial for effective data sharing and collaboration among healthcare providers.

Future Prospects

Expansion into New Regions: With a strong presence in the UK and Ireland, companies like Doccla are eyeing expansion into the DACH region (Germany, Austria, Switzerland) and France, where there is growing interest in digital health solutions. Tailoring services to local market needs and regulatory requirements will be key.

Integration with AI and Big Data: The use of AI and big data analytics is expected to enhance the capabilities of virtual wards and RPM systems, enabling more accurate predictions of health outcomes and personalized care plans.

Partnerships and Collaborations: Strategic partnerships with healthcare providers, technology companies, and life sciences firms will drive innovation and expand the reach of virtual ward and RPM services.

Focus on Chronic Disease Management: As the prevalence of chronic diseases continues to rise, there will be increased demand for RPM solutions that can manage long-term conditions, improve patient outcomes, and reduce healthcare costs.

 

Investment Opportunities

Key Drivers of Investment Opportunities

Aging Population and Chronic Disease Management: Europe's aging population is a primary driver for investment in virtual ward and RPM technologies. The prevalence of chronic conditions such as diabetes, cardiovascular diseases, and respiratory disorders is increasing, creating a demand for continuous monitoring and care management solutions that can be delivered in the home setting. This demographic shift underscores the need for scalable digital health solutions, providing a strong foundation for investment.

Technological Advancements: Continuous improvements in wearable devices, IoT, artificial intelligence (AI), and data analytics have made RPM more effective and user-friendly. These technologies enable real-time monitoring, predictive analytics, and personalized care plans, which are crucial for managing patient health remotely. Investors have the opportunity to back companies that are at the forefront of these technological innovations, which will drive the next wave of growth in the sector.

Post-COVID-19 Adoption and Demand: The COVID-19 pandemic accelerated the adoption of virtual care models, demonstrating the feasibility and benefits of remote patient monitoring. Healthcare providers and patients have become more accustomed to using virtual care solutions, and this behavioral shift is expected to continue, driving sustained demand for RPM technologies.

Supportive Government Policies and Funding: European governments are increasingly supportive of digital health initiatives, with policies aimed at promoting telehealth and RPM. Programs like the EU4Health initiative provide funding and guidance for digital health adoption, creating a favorable environment for investment. National telehealth strategies in countries like the UK, Germany, and France also offer structured reimbursement models and incentives for implementing virtual care solutions.

Key Areas of Investment Opportunities

Virtual Ward Platforms: Investing in companies that provide comprehensive virtual ward platforms is a significant opportunity. These platforms integrate various technologies such as wearable devices, mobile apps, and cloud-based systems to monitor patients remotely. Companies like Doccla, which offer end-to-end virtual ward solutions, are well-positioned to capture market share as healthcare providers increasingly adopt these systems to manage patient care more effectively.

Remote Monitoring Devices and IoT Solutions: The market for remote monitoring devices, including wearable sensors and IoT-enabled health monitoring tools, is growing rapidly. Investments in startups and established companies developing innovative monitoring devices that are user-friendly, accurate, and capable of tracking a wide range of health parameters (e.g., heart rate, oxygen saturation, glucose levels) present a lucrative opportunity. These devices are critical for chronic disease management and continuous patient monitoring.

AI and Data Analytics in Healthcare: AI and machine learning are transforming the RPM industry by enabling predictive analytics, early detection of health issues, and personalized care plans. Investing in companies that leverage AI to analyze health data, generate actionable insights, and improve patient outcomes can provide substantial returns. AI-driven healthcare analytics is a high-growth area, with applications extending beyond monitoring to include diagnostics, treatment optimization, and population health management.

Interoperability and Integration Solutions: As the demand for integrated healthcare systems grows, investing in companies that focus on interoperability solutions will be crucial. These companies provide platforms and tools that ensure seamless data exchange between different healthcare systems, electronic health records (EHRs), and RPM devices. This integration is essential for creating a cohesive healthcare ecosystem that supports effective patient care.

Chronic Disease Management Programs: Investments in virtual care programs specifically designed for managing chronic diseases offer significant growth potential. These programs typically include a combination of remote monitoring, patient education, and virtual consultations to manage conditions such as diabetes, hypertension, and heart failure. Companies that develop comprehensive chronic care management solutions that can be easily scaled across different healthcare settings will attract investor interest.

Home Care and Elderly Care Solutions: With an increasing number of elderly patients preferring to receive care at home, there is a growing market for home-based care solutions that incorporate RPM. Investment in companies that specialize in elderly care through virtual wards and RPM services will cater to this expanding market segment. Technologies that enable early intervention and reduce the need for hospital visits can improve quality of life for elderly patients and reduce healthcare costs.

Market Expansion Opportunities

Geographical Expansion: Companies that are currently successful in specific European markets, such as Doccla in the UK and Ireland, present attractive investment opportunities as they seek to expand into new regions. The DACH region (Germany, Austria, Switzerland), France, and Southern European countries offer untapped markets with growing interest in digital health solutions. Investment in companies with strong expansion strategies can provide access to these emerging markets.

Cross-Sector Collaborations: Collaborations between digital health companies and traditional healthcare providers, pharmaceutical companies, and insurance firms offer investment opportunities. Such partnerships can enhance service offerings, integrate RPM into clinical trials and patient care pathways, and create comprehensive health management solutions. Investment in companies that foster strategic collaborations can lead to innovative products and expanded market reach.

Life Sciences and Pharmaceutical Integration: The integration of RPM into the life sciences sector, particularly for clinical trials and real-world evidence collection, is an emerging area of investment. Pharmaceutical companies increasingly require continuous monitoring of trial participants and post-market surveillance of drugs. Investing in RPM companies that provide specialized solutions for the life sciences industry can offer new revenue streams and market expansion opportunities.

Challenges to Consider

Regulatory Compliance: Navigating the complex regulatory environment in Europe is a challenge for companies in the virtual ward and RPM sector. Investors should consider companies that have robust compliance frameworks and experience in dealing with diverse regulations across different countries.

Data Security and Privacy: Ensuring the security of patient data is critical. Investors should look for companies with strong data protection measures and cybersecurity protocols to safeguard against data breaches and comply with GDPR.

Reimbursement and Funding Models: Inconsistent reimbursement policies across Europe can impact the adoption of RPM solutions. Investors should target markets with established reimbursement frameworks or companies that have strategies to navigate reimbursement challenges effectively.

Adoption by Healthcare Professionals: Resistance to adopting new technologies can slow down market growth. Companies that invest in training, education, and demonstrating the clinical benefits of virtual wards and RPM will have a better chance of gaining traction among healthcare providers.

 

Related Market Reports From QY Research

 

QY Research Releases Comprehensive Market Reports on the virtual ward and remote patient monitoring Market, as shown in the links below. These reports provide an in-depth analysis of the current market landscape, key trends, and future growth opportunities.

Global Virtual Ward Market Insights, Forecast to 2030

https://www.qyresearch.com/reports/2866284/virtual-ward

Virtual Ward - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

https://www.qyresearch.com/reports/2218105/virtual-ward

Global Remote Patient Monitors Market Insights, Forecast to 2030

https://www.qyresearch.com/reports/2838987/remote-patient-monitors

Remote Patient Monitors - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

https://www.qyresearch.com/reports/2577614/remote-patient-monitors

 

Contact Information

QY Research Switzerland

Chemin des Mines 2, 1202 Geneva, GE, Switzerland

+41765899438

John Yaoen Wang

john@qyresearch.com